Release Date: 11/11/19 16:17 Summary: Update on merger with AIS Anywhere Price Sensitive: Yes Download Document 230.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%